DRREDDY's weekly performance was lackluster, with a return of -0.34% and a Sharpe Ratio of -0.11, indicating poor risk-adjusted returns. The stock's volatility was moderate at 11.85%, which is relatively lower compared to its peers. In comparison to its peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but outperformed HINDUNILVR. Overall, the stock was moderately risky this week.

[Volatility: 11.85%]